Nimesulida Alter (Nimesulide)

• Nimesulide is an NSAID that reduces inflammation and pain by targeting the cyclo‑oxygenase pathway.
• Acute pain: provides rapid relief of short‑term pain episodes.
• Musculoskeletal pain: alleviates pain and inflammation associated with strains, sprains and osteoarthritis.
• Dysmenorrhea: reduces menstrual cramps and associated discomfort.
• Fever: lowers elevated body temperature in febrile conditions.

• Nimesulide preferentially inhibits the cyclo‑oxygenase‑2 (COX‑2) enzyme, decreasing the conversion of arachidonic acid to prostaglandins that mediate inflammation, pain and fever. By sparing COX‑1 activity, it aims to preserve gastric mucosal protection while delivering anti‑inflammatory and analgesic effects. The reduced prostaglandin synthesis leads to diminished sensitization of peripheral nociceptors and lowered hypothalamic set‑point for temperature regulation, contributing to its analgesic and antipyretic properties.

Nimesulide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness: transient vertigo or light‑headedness.
• Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects

• Hepatotoxicity: elevated liver enzymes or severe liver injury.
• Severe allergic reactions: anaphylaxis, angioedema or Stevens‑Johnson syndrome.
• Renal impairment: acute kidney injury or reduced renal function.
• Cardiovascular events: increased risk of thrombotic events or hypertension.

When prescribing Nimesulide, clinicians should observe several safety considerations to minimize risk.

• Assess liver function: evaluate baseline hepatic enzymes before initiating therapy.
• Monitor renal status: avoid use in patients with severe kidney impairment.
• Limit duration: restrict treatment to the shortest effective period, typically not exceeding 15 days.
• Avoid in ulcer history: contraindicated in active peptic ulcer disease or gastrointestinal bleeding.
• Caution with anticoagulants: may increase bleeding tendency when combined with warfarin or other anticoagulants.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nimesulide can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Anticoagulants: increased risk of bleeding when combined with warfarin or direct oral anticoagulants.
• Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity and renal impairment.
• Hepatotoxic drugs: concurrent use with paracetamol, isoniazid or methotrexate may exacerbate liver injury.

Moderate Interactions (Monitor Closely)

• Antihypertensives: may reduce the effect of ACE inhibitors or diuretics.
• Lithium: NSAIDs can raise lithium serum levels, requiring monitoring.
• Methotrexate (low dose): may increase methotrexate toxicity; dose adjustment may be needed.